EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma

Gerd Jomrich, Winny Yan, Dagmar Kollmann, Ivan Kristo, Daniel Winkler, Hannah Puhr, Aysegül Lhan-Mutlu, Marlene Hollenstein, Reza Asari, Sebastian F Schoppmann

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05976-z ↗

At a glance

Journal article in Journal of Cancer Research and Clinical Oncology, 2024. Written by Gerd Jomrich and 9 co-authors. Institution: Department of General Surgery, Gastroesophageal Tumor Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria. Major MEDLINE topics: Fibrinogen, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms. Cited 3 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical University of Vienna.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

Serum fibrinogen and albumin play important roles in systemic inflammation and are implicated in tumor progression. The fibrinogen-to-albumin ratio (FAR) has shown a prognostic impact in several malignancies. This study aims to assess the prognostic value of the pretherapeutic FAR in patients with adenocarcinoma of the gastroesophageal junction (AEG) who underwent upfront resection.

Methods

Consecutive patients who underwent surgical resection at the Department of Surgery at the Medical University of Vienna between 1992 and 2014 were included into this study. Optimal cut-off values were determined with the receiver-operating characteristic (ROC) curve, uni- and multivariate analyzes were calculated by the Cox proportional hazard regression model for overall survival (OS).

Results

Among 135 included patients, the majority were male (79.26%), with a mean age of 66.53 years. Elevated FAR correlated significantly ( p = 0.002) with shorter OS in univariate analysis, also confirmed as independent prognostic factor ( p = 0.005) in multivariable analysis. The ROC curve of FAR (AUC = 0.744) outperformed fibrinogen (AUC = 0.738) and albumin (AUC = 0.378) in predicting OS for AEG patients.

Conclusion

The FAR serves as an independent prognostic factor for OS in patients undergoing primarily resection for AEG. Given its routine availability and ease of calculation, FAR could help in diagnosis and treatment selection for AEG patients. Further validation studies are warranted to confirm these findings conclusively.

Subjects

MeSH terms (MEDLINE)

FibrinogenAdenocarcinomaEsophageal NeoplasmsStomach NeoplasmsEsophagogastric JunctionHumansMaleFemaleAgedPrognosisMiddle AgedSerum AlbuminBiomarkers, TumorRetrospective StudiesAged, 80 and overAdultROC Curve

Author keywords

Esophageal cancerFibrinogen to albumin ratioMalignant tumorPrognosisPrognostic parameter

Substances

FibrinogenSerum AlbuminBiomarkers, Tumor

Authors and institutions

  • Department of General Surgery, Gastroesophageal Tumor Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Vienna University of Economics and Business, Vienna, Austria.
  • Department of Medicine 1, Division of Oncology, Gastroesophageal Tumor Unit, Medical University of Vienna, Comprehensive Cancer Center (CCC), Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of General Surgery, Gastroesophageal Tumor Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria. sebastian.schoppmann@meduniwien.ac.at.

Funding

  • Medical University of Vienna

Cite

APA

Jomrich, G., Yan, W., Kollmann, D., Kristo, I., Winkler, D., Puhr, H., Lhan-Mutlu, A., Hollenstein, M., Asari, R., & Schoppmann, S. F. (2024). Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05976-z

Vancouver

Jomrich G, Yan W, Kollmann D, Kristo I, Winkler D, Puhr H, et al. Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05976-z

BibTeX
@article{Jomrich2024,
  author = {Jomrich, Gerd and Yan, Winny and Kollmann, Dagmar and Kristo, Ivan and Winkler, Daniel and Puhr, Hannah and Lhan-Mutlu, Aysegül and Hollenstein, Marlene and Asari, Reza and Schoppmann, Sebastian F},
  title = {Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05976-z}
}
Start for free →